WallStSmart
AUTL

Autolus Therapeutics Ltd

NASDAQ: AUTL · HEALTHCARE · BIOTECHNOLOGY

$1.41
+0.00% today

Updated 2026-04-30

Market cap
$383.25M
P/E ratio
P/S ratio
355.35x
EPS (TTM)
$-1.08
Dividend yield
52W range
$1 – $3
Volume
1.7M

Autolus Therapeutics Ltd (AUTL) Earnings

Quarterly earnings history, analyst estimates, and stock price reaction.

EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+12.0%
Last 4 quarters
Revenue YoY growth
Most recent quarter
EPS YoY growth
+100.0%
Most recent quarter

Earnings surprise history (last 12 quarters)

Beat estimate Missed estimate

Quarterly EPS and revenue trend

Quarterly revenue EPS (diluted)

How the stock reacts to earnings

Avg 1-day reaction
-9.2%
Last 2 reports
Positive reaction rate
0%
0 of 2 quarters
Largest single-day move
-14.7%
2025-11-12
Report dateEPS actualSurpriseClose beforeClose after1-day reaction
2026-03-10$-0.34-35.7%$1.62$1.56-3.7%
2025-11-12$-0.30-38.2%$1.50$1.28-14.7%

Quarterly earnings history

Fiscal quarter endingEPS estimateEPS actualSurpriseRevenueYoY revenue
2026-03-31$-0.25$0.00+100.0%
2025-12-31$-0.25$-0.34-35.7%$24.25M+83534.2%
2025-09-30$-0.22$-0.30-38.2%$21.19M
2025-06-30$-0.23$-0.18+21.7%$20.92M
2025-03-31$-0.26$-0.26+0.0%$8.98M-11.0%
2024-12-31$-0.21$-0.09+56.3%$29000.00-98.4%
2024-09-30$-0.21$-0.31-47.6%
2024-06-30$-0.19$-0.22-15.8%
2024-03-31$-0.05$-0.24-380.0%$10.09M
2023-12-31$-0.25$-0.45-80.0%$1.77M
2023-09-30$-0.25$-0.26-4.0%$406000.00
2023-06-30$-0.22$-0.26-18.2%

Frequently asked questions

Has Autolus Therapeutics Ltd beaten earnings estimates?
Autolus Therapeutics Ltd has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +12.0% over the last 4 quarters.
How does AUTL stock react to earnings?
AUTL stock has moved an average of -9.2% in the trading day following earnings over its last 2 reports, with positive reactions in 0% of those quarters.